Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy
Launched by KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER · Sep 28, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background: Liver transplantation is a primary treatment for end-stage liver disease, enhancing survival rates and life quality. Living donor liver transplantation (LDLT) has gained prominence due to the scarcity of deceased donor organs. Historically, the open technique dominated living donor hepatectomies. However, advances in minimally invasive surgery (MIS) led to laparoscopic and later robotic procedures. With the introduction of robotic surgery, MIS for complex surgeries improved, offering better precision and ergonomics.
Objective: To compare the short and long-term outcomes of open...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All donor and recipient pairs that underwent LDLT at the study institution
- • Between 01 January 2011 to 31 March 2023
- • Both adult-to-adult and adult-to-pediatric LDLT are included.
- Exclusion Criteria:
- • Dual and domino LDLT are excluded.
About King Faisal Specialist Hospital & Research Center
King Faisal Specialist Hospital & Research Center (KFSH&RC) is a leading medical institution in Saudi Arabia, dedicated to providing advanced healthcare services, conducting pioneering research, and training healthcare professionals. Founded in 1975, KFSH&RC specializes in comprehensive patient care across various disciplines, including oncology, organ transplantation, and genetics. The center is recognized for its commitment to clinical excellence and innovation, actively participating in clinical trials to enhance treatment options and improve patient outcomes. With state-of-the-art facilities and a multidisciplinary team of experts, KFSH&RC plays a pivotal role in advancing medical knowledge and improving healthcare standards in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Riyadh, , Saudi Arabia
Patients applied
Trial Officials
Dieter C Broering, MD, PhD
Principal Investigator
Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported